MyoScience, Inc. Company Profile

00:36 EDT 25th September 2017 | BioPortfolio

News Articles [4 Associated News Articles listed on BioPortfolio]

Myoscience's knee osteoarthritis treatment device wins FDA clearance

The FDA has granted Myoscience 510(k) clearance for its Iovera device, a nonopioid and nonsystemic treatment for providing re -More- 

FDA approves new indication for Myoscience's knee osteoarthritis device

The US Food & Drug Administration (FDA) has approved new indication for Myoscience's iovera° device to relieve pain and symptoms associated with osteoarthritis of the knee.

Bay Area's MyoScience Wins FDA Nod for Iovera Knee Osteoarthritis Device

  Life Sciences Jobs   ...

FDA Clears Iovera Cold Treatment Device for Knee OA Pain

The iovera technology from Myoscience, Inc, is a nonopioid, nonsystemic treatment for blocking pain signals from peripheral nerves in patients with knee osteoarthritis (OA). FDA Approvals

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Study of the MyoScience Tissue Remodeling Device for Facial Rejuvenation

A prospective, non-randomized study to evaluate the performance of the MyoScience Tissue Remodeling Device for the treatment of glabellar lines (frown lines), lateral orbital lines (crow's...

More Information about "MyoScience, Inc." on BioPortfolio

We have published hundreds of MyoScience, Inc. news stories on BioPortfolio along with dozens of MyoScience, Inc. Clinical Trials and PubMed Articles about MyoScience, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MyoScience, Inc. Companies in our database. You can also find out about relevant MyoScience, Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record